Every Form 4 that Incannex Healthcare Limited (IXHL) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow IXHL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IXHL filings page.
Incannex Healthcare (IXHL) director Troy Valentine reported acquiring 11,302,608 shares of common stock at $0 on November 14, 2025, as a restricted stock grant under the company’s 2023 Equity Incentive Plan. Following the grant, he beneficially owned 12,001,858 shares directly.
The restricted shares vest in four tranches of 2,825,652 each on December 10, 2025; June 30, 2026; June 30, 2026; and June 30, 2027. He also reported indirect holdings, including 242,862 shares via Alignment Capital Pty Ltd.
Incannex Healthcare (IXHL) director Robert Clark reported acquiring 1,686,956 shares of common stock on 11/14/2025 at $0, granted as restricted stock under the 2023 Equity Incentive Plan. Following the grant, he beneficially owns 1,786,956 shares, held directly.
The award vests in four tranches: 421,739 on December 10, 2025; 421,739 on June 30, 2026; 421,739 on June 30, 2026; and 421,739 on June 30, 2027.
Incannex Healthcare (IXHL) reported a director’s Form 4 showing an acquisition of 1,686,956 shares of restricted common stock at $0 on November 14, 2025 under the company’s 2023 Equity Incentive Plan. The award vests in four tranches: 421,739 on December 10, 2025, 421,739 on June 30, 2026, another 421,739 on June 30, 2026, and 421,739 on June 30, 2027. Following the grant, the reporting person beneficially owns 1,957,803 shares, held directly.
Incannex Healthcare (IXHL) reported an insider equity grant. The company’s CFO, Treasurer and Secretary received 869,565 shares of common stock at $0 on 11/14/2025, reported as an acquisition. Following the grant, beneficial ownership stands at 921,358 shares, held directly. The award is restricted stock under the 2023 Equity Incentive Plan, vesting in three equal tranches of 289,855 shares on 12/10/2025, 06/30/2026, and 06/30/2027.
Incannex Healthcare (IXHL) reported an insider equity grant on Form 4. CEO/President and Director Joel Latham acquired 22,608,692 shares of common stock on November 14, 2025 at a price of $0 (transaction code A). Following the grant, his beneficial ownership stands at 24,186,177 shares, held directly.
The filing states these are restricted shares granted under the company’s 2023 Equity Incentive Plan, with vesting in four equal tranches of 5,652,173 shares each: December 10, 2025, June 30, 2026 (two tranches), and June 30, 2027. This outlines the schedule by which the award becomes fully vested over time.
Incannex Healthcare (IXHL) director George Anastassov reported an acquisition of 1,686,956 shares of common stock on 11/14/2025, at a reported price of $0, reflecting a restricted stock grant under the 2023 Equity Incentive Plan. Following the transaction, he beneficially owns 2,456,677 shares, held directly.
The grant includes four equal tranches of 421,739 shares scheduled to vest on Dec 10, 2025, Jun 30, 2026 (two tranches), and Jun 30, 2027.